Norbrook releases Hexasol Injection antibiotic

February 28, 2011

0311pc_np_norbrook_1 Hexasol Injection is indicated for the treatment of bacterial pneumonia associated with Pasteurella spp. and for the control of associated pyrexia (fever) in beef and non-lactating dairy cattle.

The dual-action formulation of Hexasol Injection offers veterinarians and cattle producers a practical choice when combined antibiotic and antipyretic action is indicated.

Key attributes of Hexasol Injection include proven safe and effective ingredients, the convenience of a SQ or IM dosing option and a relatively short withdrawal time prior to slaughter of 21 days.

All presented at lower dose volume, and more economically, than competitive products with combined antibiotic and antipyretic ingredients.

Hexasol Injection is available by prescription only.

—Norbrook press release

PHOTO
Hexasol Injection combines an antibiotic and non-steroidal anti-inflammatory drug in one convenient dose.
Photo courtesy Norbrook.

BUYER'S GUIDE

VISIT OUR BUYER’S GUIDE

With more than 80 patents and more than 20 inventions specifically designated to animal agriculture, we lead the way in providing advanced, comprehensive and integrated animal management systems and solutions.

As the world's leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70 years innovating ways to predict, prevent, detect and treat animal illness, Zoetis...

Established in December 1982, American Animal Health, Inc. (AAH) has been a trusted partner for cattlemen for over 40 years. We specialize in supporting livestock health through our commercial bacterin-toxoid and autogenous bacterin services.